)
Edge14 Nov 2025
Ball: The King of Cans
From a 19th-century glass-jar legacy to a global plant network, Ball is now a pure-play aluminum can partner to the world's biggest beverage brands.
Co-Diagnostics (CODX) investor relations material
Co-Diagnostics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary13 Nov, 2025
Executive summary
Multiple strategic initiatives underway, including a planned SPAC transaction for the Indian joint venture CoSara, the launch of the CoMira joint venture in the MENA region, and a new AI business unit integrating diagnostics and predictive analytics.
Clinical evaluations for a multiplex upper respiratory test (Flu A, B, COVID-19, RSV) are imminent, supported by NIH grants, with additional tests for tuberculosis and HPV on track for clinical trials.
Recent direct offerings raised $10.8 million, strengthening the balance sheet and supporting commercialization efforts.
The company is developing a point-of-care PCR platform, with regulatory submission plans after withdrawing a previous FDA application.
In-silico analysis confirmed high reactivity of CHIKV primers against recent virus strains.
Financial highlights
Q3 2025 revenue was $0.1 million, down from $0.6 million in Q3 2024, mainly due to lower grant revenue.
Operating expenses decreased to $7.1 million from $10.6 million year-over-year, reflecting improved operational efficiency.
Net loss narrowed to $5.9 million ($0.16 per share) from $9.7 million ($0.32 per share) in Q3 2024.
Adjusted EBITDA loss improved to $6.3 million from $8.8 million year-over-year.
Ended the quarter with $11.4 million in cash, cash equivalents, and marketable securities.
Outlook and guidance
Focus remains on advancing the development pipeline, completing clinical evaluations, and preparing for regulatory submissions.
Multiple commercial launches anticipated in 2026, with ongoing development of new diagnostic tests.
Capital requirements to be met through a mix of equity, debt, grant funding, and operational efficiencies.
The company expects to continue generating operating losses and using cash in operations in the near term.
There is substantial doubt about the company's ability to continue as a going concern without additional financing.
CoSara SPAC's impact on 2026 commercialization?
CoMira's strategy for MENA regulatory acceptance?
AI unit's role in predictive epidemiology?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Co-Diagnostics earnings date
Q4 202519 Mar, 2026
Next Co-Diagnostics earnings date
Q4 202519 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Co-Diagnostics, Inc. is a molecular diagnostics company that develops and manufactures diagnostic testing products. The company's core focus is on creating and commercializing molecular technologies that detect infectious diseases, as well as other genetic conditions. Co-Diagnostics utilizes its proprietary CoPrimer technology to design highly accurate and cost-effective diagnostic tests. The company serves the healthcare sector, offering its products to laboratories, hospitals, and healthcare providers globally, with applications in human diagnostics, agriculture, and animal testing. The company is headquartered in Salt Lake City, Utah, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage